Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination

Journal of Surgical Oncology

Volumn 98, Issue 4, 2008, Pages 263-267

  Esquivel, Jesus ^a   Elias, Dominique ^b   Baratti, Dario ^c   Kusamura, Shigeki ^c   Deraco, Marcello ^c  

^a ST AGNES HOSPITAL   (United States)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cytoreductive surgery; Intraperitoneal chemotherapy; Peritoneal carcinomatosis

Indexed keywords

CANCER CHEMOTHERAPY; COLORECTAL CANCER; CONFERENCE PAPER; CONSENSUS; CYTOREDUCTIVE SURGERY; EVALUATION; HUMAN; LAPAROSCOPY; PERITONEAL CARCINOMATOSIS; PERITONEAL DISEASE; PERITONEAL DISSEMINATION; PERITONEUM CANCER; PRIORITY JOURNAL;

CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; CONSENSUS; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; PERITONEAL NEOPLASMS; PRACTICE GUIDELINES AS TOPIC;

EID: 50849099547     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21053     Document Type: Conference Paper

References (20)

1. Hurwitz HI, Fehrenbacher L, Hainsworth JD, et al.: Bevacizumab in combination with fluorouracil and leucovorin: An active regimen for first-line metastatic colorectal cancer. J. Clin Oncol 2005;23:3502-3508.
2. Sadeghi B, Arvieux C, Glehen O, et al.: Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer 2000;88:58-63.
3. Sugarbaker PH: New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome. Lancet Oncol 2006;7:69-76.
4. Sugarbaker PH, Graves T, DeBruijn EA, et al.: Rationale for early post-operative intraperitoneal chemotherapy (EPIC) in patients with advanced gastrointestinal cancer. Cancer Res 1990;50:5790-5794.
5. Look M, Chang D, Sugarbaker PH: Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer 2004;14:35-41.
6. Carmignani CP, Ortega-Perez G, Sugarbaker PH: The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer. Eur J Surg Oncol 2004;30:391-398.
7. Glehen O, Cotte E, Schreiber V, et al.: Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg 2004;91:747-754.
8. Elias D, Delperro JR, Sideris L, et al.: Treatment of peritoneal carcinomatosis from colorectal cancer: Impact of complete cytoreductive surgery and difficulties in conducting randomized trials. Ann Surg Oncol 2004;11:518-521.
9. Elias D, Raynard B, Farkhondeh F, et al.: Peritoneal carcinomatosis of colorectal origin: Long-term results of intraperitoneal chemohyperthermia with oxaliplatin following complete cytoreductive surgery. Gastroenterol Clin Biol 2006;30:1200-1204.
10. Verwaal VJ, van Tinteren H, van Ruth S, et al.: Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg 2004;91:739-746.
11. Verwaal VJ, van Ruth S, de Bree E, et al.: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal origin. J. Clin Oncol 2003;21:3737-3743.
12. Glehen O, Kwiatkowski F, Sugarbaker PH, et al.: Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J. Clin Oncol 2004;22:3284-3292.
13. Yan TD, Black D, Savady R, et al.: A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J. Clin Oncol 2006;24:4011-4019.
14. Esquivel J, Sticca R, Sugarbaker PH, et al.: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement. Ann Surg Oncol 2007;14:128-133.
15. de Bree E, Koops W, Kroger R, et al.: Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2005.
16. Yan TD, Haveric N, Carmignani CP, et al.: Computed tomographic characterization of malignant peritoneal mesothelioma. Tumori 2005;91:394-400.
17. Garofalo A, Valle M: Staging videolaparoscopy of peritoneal carcinomatosis Tumori 2003;89:70-77. Review, Italian.
18. Pomel C, Appleyard TL, Gouy S, et al.: The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2005;31(5):540-543.
19. Sugarbaker PH: Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999;43:S15-S25.
20. Verwaal VJ, van Tinteren H, van Ruth S, et al.: Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg 2004;91:739-746.